< Back to previous page
Researcher
Charlotte Rigauts
- Keywords:Anti-inflammatory bacteria
- Disciplines:Microbiome, Immunology not elsewhere classified
Affiliations
- Department of Pharmaceutical analysis (Department)
Member
From1 Jul 2015 → 31 Dec 2021
Projects
1 - 1 of 1
- Exploring and exploiting the cystic fibrosis lung microbiome to
design novel anti-inflammatory therapiesFrom1 Jan 2017 → 31 Dec 2020Funding: FWO Strategic Basic Research Grant
Publications
1 - 5 of 5
- Commensal bacteria of the lung microbiota synergistically inhibit inflammation in a three-dimensional epithelial cell model(2023)
Authors: Ellen Goeteyn, Lucia Grassi, Sara Van den Bossche, Charlotte Rigauts, Yannick Vande Weygaerde, Eva Van Braeckel, Ken Bracke, Aurélie Crabbé
- Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease(2022)
Authors: Charlotte Rigauts, Juliana Aizawa, Steven Taylor, Geraint B. Rogers, Matthias Govaerts, Paul Cos, Lisa Ostyn, Sarah Sims, Eva Vandeplassche, Mozes Sze, et al.
- Exploring the effects of non-pathogenic respiratory microbiome members on inflammation in models of chronic airway disease(2020)
Authors: Charlotte Rigauts
- Host metabolites stimulate the bacterial proton motive force to enhance the activity of aminoglycoside antibiotics(2019)
Authors: Aurélie Crabbé, Lisa Ostyn, Sorien Staelens, Charlotte Rigauts, Martijn Risseeuw, Maarten Dhaenens, Simon Daled, Heleen Van Acker, Dieter Deforce, Serge Van Calenbergh, et al.
- Influence of three-dimensional lung epithelial cells and interspecies interactions on antibiotic efficacy against Mycobacterium abscessus and Pseudomonas aeruginosa(2018)
Authors: Graciela Rodriguez-Sevilla, Charlotte Rigauts, Eva Vandeplassche, Lisa Ostyn, Ignacio Mahillo-Fernandez, Jaime Esteban, Concepcion Perez-Jorge Peremarch, Aurélie Crabbé